{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T18:36:20Z","timestamp":1793039780018,"version":"4.5.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.lfs.2019.116546","type":"journal-article","created":{"date-parts":[[2019,6,6]],"date-time":"2019-06-06T11:43:23Z","timestamp":1559821403000},"page":"116546","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Galectin-3 aggravates pulmonary arterial hypertension via immunomodulation in congenital heart disease"],"prefix":"10.1016","volume":"232","author":[{"given":"Qiang","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingsong","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2019.116546_bb0005","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1471-2261-10-9","article-title":"Hemodynamics in pulmonary arterial hypertension (pah): do they explain long-term clinical outcomes with pah-specific therapy?","volume":"10","author":"Steele","year":"2010","journal-title":"BMC Cardiovasc. Disord."},{"key":"10.1016\/j.lfs.2019.116546_bb0010","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1161\/CIRCULATIONAHA.115.018435","article-title":"Effect of warfarin treatment on survival of patients with pulmonary arterial hypertension (pah) in the registry to evaluate early and long-term pah disease management (reveal)","volume":"132","author":"Preston","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.lfs.2019.116546_bb0015","doi-asserted-by":"crossref","first-page":"576","DOI":"10.3346\/jkms.2015.30.5.576","article-title":"The effect of umbilical cord blood derived mesenchymal stem cells in monocrotaline-induced pulmonary artery hypertension rats","volume":"30","author":"Lee","year":"2015","journal-title":"J. Korean Med. Sci."},{"key":"10.1016\/j.lfs.2019.116546_bb0020","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.ijcard.2016.06.192","article-title":"Thymoquinone attenuates monocrotaline-induced pulmonary artery hypertension via inhibiting pulmonary arterial remodeling in rats","volume":"221","author":"Zhu","year":"2016","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.lfs.2019.116546_bb0025","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1183\/09031936.00090614","article-title":"Riociguat for the treatment of pulmonary arterial hypertension: a long-term extension study (patent-2)","volume":"45","author":"Rubin","year":"2015","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.lfs.2019.116546_bb0030","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.jacc.2011.03.033","article-title":"Diagnosis of pulmonary hypertension in the congenital heart disease adult population impact on outcomes","volume":"58","author":"Lowe","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.lfs.2019.116546_bb0035","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1161\/CIRCULATIONAHA.105.592386","article-title":"Pulmonary vascular disease in adults with congenital heart disease","volume":"115","author":"Diller","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.lfs.2019.116546_bb0040","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.12659\/MSM.905654","article-title":"Characteristics of pulmonary vascular remodeling in a novel model of shunt-associated pulmonary arterial hypertension","volume":"24","author":"Zhang","year":"2018","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.lfs.2019.116546_bb0045","article-title":"Pulmonary arterial hypertension in congenital heart disease: current perspectives and future challenges","author":"Giannakoulas","year":"2016","journal-title":"Hell. J. Cardiol."},{"key":"10.1016\/j.lfs.2019.116546_bb0050","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jchf.2014.08.002","article-title":"The impact of galectin-3 inhibition on aldosterone-induced cardiac and renal injuries","volume":"3","author":"Calvier","year":"2015","journal-title":"JACC Heart Fail."},{"key":"10.1016\/j.lfs.2019.116546_bb0055","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1161\/ATVBAHA.112.300569","article-title":"Galectin-3 mediates aldosterone-induced vascular fibrosis","volume":"33","author":"Calvier","year":"2013","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.lfs.2019.116546_bb0060","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1136\/heartjnl-2015-308365","article-title":"Galectin-3 and aldosterone as potential tandem biomarkers in pulmonary arterial hypertension","volume":"102","author":"Calvier","year":"2016","journal-title":"Heart"},{"key":"10.1016\/j.lfs.2019.116546_bb0065","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.jash.2017.07.009","article-title":"Galectin-3 mediates pulmonary vascular remodeling in hypoxia-induced pulmonary arterial hypertension","volume":"11","author":"Luo","year":"2017","journal-title":"J. Am. Soc. Hypertens."},{"key":"10.1016\/j.lfs.2019.116546_bb0070","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3892\/mmr.2016.6020","article-title":"Galectin-3 inhibition ameliorates hypoxia-induced pulmonary artery hypertension","volume":"15","author":"Hao","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.lfs.2019.116546_bb0075","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1136\/heartjnl-2017-312070","article-title":"Prognostic value of galectin-3 in adults with congenital heart disease","volume":"104","author":"Baggen","year":"2018","journal-title":"Heart"},{"key":"10.1016\/j.lfs.2019.116546_bb0080","doi-asserted-by":"crossref","first-page":"798","DOI":"10.7150\/ijbs.9470","article-title":"Up-regulated lipocalin-2 in pulmonary hypertension involving in pulmonary artery smc resistance to apoptosis","volume":"10","author":"Wang","year":"2014","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.lfs.2019.116546_bb0085","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1161\/ATVBAHA.113.302062","article-title":"Soluble jagged1 inhibits pulmonary hypertension by attenuating notch signaling","volume":"33","author":"Xiao","year":"2013","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.lfs.2019.116546_bb0090","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1177\/1074248412457046","article-title":"Gene transfer therapy by either type 1 or type 2 adeno-associated virus expressing human prostaglandin i2 synthase gene is effective for treatment of pulmonary arterial hypertension","volume":"18","author":"Kataoka","year":"2013","journal-title":"J. Cardiovasc. Pharmacol. Ther."},{"issue":"e1116","key":"10.1016\/j.lfs.2019.116546_bb0095","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.jaci.2014.04.035","article-title":"Myeloid-derived suppressor cell function is diminished in aspirin-triggered allergic airway hyperresponsiveness in mice","volume":"134","author":"Shi","year":"2014","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.lfs.2019.116546_bb0100","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.lfs.2018.08.071","article-title":"Resveratrol inhibits monocrotaline-induced pulmonary arterial remodeling by suppression of sphk1-mediated nf-kappab activation","volume":"210","author":"Shi","year":"2018","journal-title":"Life Sci."},{"key":"10.1016\/j.lfs.2019.116546_bb0105","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1084\/jem.20171767","article-title":"Inhibition of crth2-mediated th2 activation attenuates pulmonary hypertension in mice","volume":"215","author":"Chen","year":"2018","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.lfs.2019.116546_bb0110","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/ni.1983","article-title":"Ecm1 controls t(h)2 cell egress from lymph nodes through re-expression of s1p(1)","volume":"12","author":"Li","year":"2011","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.lfs.2019.116546_bb0115","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.4049\/jimmunol.182.2.1167","article-title":"Galectin-3 deficiency reduces the severity of experimental autoimmune encephalomyelitis","volume":"182","author":"Jiang","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.lfs.2019.116546_bb0120","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.atherosclerosissup.2012.10.029","article-title":"Immunoadsorption therapy for dilated cardiomyopathy and pulmonary arterial hypertension","volume":"14","author":"Dandel","year":"2013","journal-title":"Atheroscler. Suppl."},{"key":"10.1016\/j.lfs.2019.116546_bb0125","doi-asserted-by":"crossref","first-page":"3850","DOI":"10.1038\/s41467-018-06376-x","article-title":"Alpha-enolase regulates the malignant phenotype of pulmonary artery smooth muscle cells via the ampk-akt pathway","volume":"9","author":"Dai","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.lfs.2019.116546_bb0130","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20061468","article-title":"Caffeic acid phenethyl ester rescues pulmonary arterial hypertension through the inhibition of akt\/erk-dependent pdgf\/hif-1alpha in vitro and in vivo","volume":"20","author":"Cheng","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2019.116546_bb0135","doi-asserted-by":"crossref","DOI":"10.3390\/nu11030583","article-title":"Anti-remodeling effects of xanthohumol-fortified beer in pulmonary arterial hypertension mediated by erk and akt inhibition","volume":"11","author":"Silva","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.lfs.2019.116546_bb0140","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1161\/CIRCULATIONAHA.109.911818","article-title":"Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management era","volume":"122","author":"Humbert","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.lfs.2019.116546_bb0145","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1183\/09031936.00196611","article-title":"Predicting survival in pulmonary arterial hypertension in the Uk","volume":"40","author":"Lee","year":"2012","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.lfs.2019.116546_bb0150","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.tibs.2016.11.003","article-title":"Translating the 'sugar code' into immune and vascular signaling programs","volume":"42","author":"Cerliani","year":"2017","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.lfs.2019.116546_bb0155","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/8696543","article-title":"Galectin-1 as an emerging mediator of cardiovascular inflammation: mechanisms and therapeutic opportunities","volume":"2018","author":"Seropian","year":"2018","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.lfs.2019.116546_bb0160","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1007\/s00380-015-0691-z","article-title":"Galectin-3 levels are associated with right ventricular functional and morphologic changes in pulmonary arterial hypertension","volume":"31","author":"Fenster","year":"2016","journal-title":"Heart Vessel."},{"key":"10.1016\/j.lfs.2019.116546_bb0165","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/1471-2172-12-60","article-title":"Transfer of in vivo primed transgenic t cells supports allergic lung inflammation and fizz1 and ym1 production in an il-4ralpha and stat6 dependent manner","volume":"12","author":"Dasgupta","year":"2011","journal-title":"BMC Immunol."},{"key":"10.1016\/j.lfs.2019.116546_bb0170","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1164\/rccm.201410-1820OC","article-title":"The causal role of il-4 and il-13 in schistosoma mansoni pulmonary hypertension","volume":"192","author":"Kumar","year":"2015","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.lfs.2019.116546_bb0175","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1365-3083.2007.01986.x","article-title":"An emerging role for galectins in tuning the immune response: lessons from experimental models of inflammatory disease, autoimmunity and cancer","volume":"66","author":"Rabinovich","year":"2007","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.lfs.2019.116546_bb0180","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.21879","article-title":"Galectin-3 contributes to vascular fibrosis in monocrotaline-induced pulmonary arterial hypertension rat model","volume":"31","author":"Wang","year":"2017","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"10.1016\/j.lfs.2019.116546_bb0185","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1164\/rccm.201202-0335OC","article-title":"Immune and inflammatory cell involvement in the pathology of idiopathic pulmonary arterial hypertension","volume":"186","author":"Savai","year":"2012","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.lfs.2019.116546_bb0190","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.ajpath.2013.06.017","article-title":"Galectin-3 modulates th17 responses by regulating dendritic cell cytokines","volume":"183","author":"Lee","year":"2013","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.lfs.2019.116546_bb0195","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/joim.12623","article-title":"Pulmonary arterial hypertension - progress in understanding the disease and prioritizing strategies for drug development","volume":"282","author":"Ghataorhe","year":"2017","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.lfs.2019.116546_bb0200","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17050761","article-title":"Molecular mechanisms of pulmonary vascular remodeling in pulmonary arterial hypertension","volume":"17","author":"Leopold","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2019.116546_bb0205","first-page":"15302","article-title":"Galectin-3 mediates the effect of pdgf on pulmonary arterial hypertension","volume":"8","author":"Guo","year":"2015","journal-title":"Int. J. Clin. Exp. Med."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320519304667?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320519304667?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T17:45:18Z","timestamp":1793036718000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320519304667"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":41,"alternative-id":["S0024320519304667"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2019.116546","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Galectin-3 aggravates pulmonary arterial hypertension via immunomodulation in congenital heart disease","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2019.116546","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"116546"}}